Opus Genetics

IRD

IRD Opus Genetics NASDAQ
Add to watchlist
--
At close :
--
  • Post market
    • Summary
    Financials
    News
    Filings
    Profile
    IRD Chart
    See on advanced chart >

    About

    Opus Genetics, Inc. is a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders. Opus's pipeline currently includes two small-molecule product candidates targeting...
    Read More
    • Highlight
      A clinical stage ophthalmic biopharmaceutical company developing treatments for hereditary retinal diseases (IRD) and other retinal and refractive disorders
      • Industry
      Pharmaceuticals
    • Exchange
      NASDAQ
    • Listing Date
      06/10/2019
    • Established Date
      Invalid Date
    • Full-time Employees
      14
    • Address
      37000 Grand River Avenue Suite 120 Farmington Hills MI
    • Tel
      1-248-9579024
    • Website
      www.ocuphire.com
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock